C R Vitt
- Molecular Biology
- Cancer Research top 10%
- Immunology
- Oncology
- Immunology and Allergy top 5%
- Co-authors
- Abla A. CreaseyLaura V. DoyleR. YamamotoMarc A. ShumanSusan M. RosenbergH Y MinJennifer R. Stratton-ThomasCatherine Zandonella
- Topics
- Antimicrobial Peptides and Activities (4 papers)Immune Response and Inflammation (3 papers)RNA Interference and Gene Delivery (3 papers)
- Journals
- Proceedings of the National Academy of SciencesThe Journal of Infectious DiseasesAntimicrobial Agents and Chemotherapy
- Partner nations
- United States
In The Last Decade
C R Vitt
12 papers receiving 622 citations
Peers
Comparison fields: 5 of 80
- Molecular Biology 351
- Cancer Research 215
- Immunology 181
- Oncology 130
- Immunology and Allergy 100
Countries citing papers authored by C R Vitt
This map shows the geographic impact of C R Vitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C R Vitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C R Vitt more than expected).
Fields of papers citing papers by C R Vitt
This network shows the impact of papers produced by C R Vitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C R Vitt. The network helps show where C R Vitt may publish in the future.
Co-authorship network of co-authors of C R Vitt
This figure shows the co-authorship network connecting the top 25 collaborators of C R Vitt. A scholar is included among the top collaborators of C R Vitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C R Vitt. C R Vitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 102 | |
| 2 | 35 | |
| 3 | 16 | |
| 4 | Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice. | 218 |
| 5 | 30 | |
| 6 | 4 | |
| 7 | 15 | |
| 8 | 29 | |
| 9 | 13 | |
| 10 | 14 | |
| 11 | 76 | |
| 12 | Biological effects of recombinant human tumor necrosis factor and its novel muteins on tumor and normal cell lines. | 119 |
About C R Vitt
C R Vitt is a scholar working on Microbiology, Immunology and Allergy and Endocrine and Autonomic Systems, having authored 12 papers that have together received 671 indexed citations. Recurring topics across this work include Antimicrobial Peptides and Activities (4 papers), Immune Response and Inflammation (3 papers) and RNA Interference and Gene Delivery (3 papers). The work is most often cited by research in Immunology and Allergy (100 citations), Cancer Research (215 citations) and Microbiology (84 citations). C R Vitt has collaborated with scholars based in United States. Frequent co-authors include Abla A. Creasey, Laura V. Doyle, R. Yamamoto, Marc A. Shuman, Susan M. Rosenberg, H Y Min, Jennifer R. Stratton-Thomas, Catherine Zandonella, Leo S. Lin and Walter H. Moos. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.